Effects of endothelin-1 and calcium channel blockers on contractions in human myometrium: A study on myometrial strips from normal and diabetic pregnant women

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 44, Issue 2, 1999, Pages 115-121

  Kaya, Tijen ^a,b   Cetin, Ali ^a   Cetin, Meral ^a   Sarioglu, Yusuf ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Istasyon Cad Secil Apt No: 33/1 ^*  (Turkey)

Author keywords

Calcium channel blockers; Diabetes, gestational; Endothelin 1; Myometrium; Pregnancy

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN 1; ISRADIPINE; NIMODIPINE; UTERUS SPASMOLYTIC AGENT;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; METABOLIC DISORDER; MUSCLE ISOMETRIC CONTRACTION; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRIORITY JOURNAL; UTERUS CONTRACTILITY; UTERUS CONTRACTION;

CALCIUM CHANNEL BLOCKERS; DIABETES, GESTATIONAL; ENDOTHELIN-1; FEMALE; HUMANS; ISRADIPINE; MYOMETRIUM; NIMODIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; REFERENCE VALUES; UTERINE CONTRACTION;

EID: 0032977055     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Yanagisawa M, Kurihara H, Kimura S: A novel potent vasoconstrictor peptide produced by vascular endothelial cell. Nature 1988;332:411-415
2. Aardal S: The physiological and pathophysiological significance of endothelins. Tidsskr Nor Laegeforen 1994;114: 2120-2124
3. Inoue A, Yanagisawa M, Kimura S, et al: The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863-2867
4. Eglen RM, Michel AD, Sharif NA, et al: The pharmacological properties of the peptide, endothelin. Br J Pharmacol 1989; 97:1297-1307
5. Word RA, Kamm KE, Stull JT, et al: Endothelin increases cytoplasmic calcium and myosin phosphorylation in human myometrium. Am J Obstet Gynecol 1990;162:1103-1108
6. Kozuka M, Ito T, Hirose S, et al: Endothelin induces two types of contractions of rat uterus: Phasic contractions by way of voltage-dependent calcium channels and developing contractions through a second type of calcium channels. Biochem Biophys Res Commun 1989;159:317-323
7. Fried G, Liu YA, Andersson E: Endothelin contracts human uterine myometrium by a partly dihydropyridine-sensitive mechanism. Acta Physiol Scand 1993;147:131-136
8. Ulmsten U, Anderson KE, Wingerup L: Treatment of premature labor with the calcium antagonist nifedipine. Arch Gynecol 1980;229:1-6
9. Belford MA, Saade GR, Moise KJ: Nimodipine in the management of preeclampsia: Maternal and fetal effects. Am J Obstet Gynecol 1994;171:417-424
10. Lunell NO, Garoff L, Grunewald C, et al: Isradipine, a new calcium antagonist: Effect on maternal and fetal hemodynamics. J Cardiovasc Pharmacol (suppl) 1991;18:37-40
11. Hakkinen LM, Voulteenaho OJ, Lappaluoto JP, et al: Endothelin in maternal and umbilical cord blood in spontaneous labor and elective cesarean section. Obstet Gynecol 1992;80:72-75
12. Schwartz JG, Phillips WT, Blumhardt MR, et al: Use of a more physiologic oral glucose solution during screening for gestational diabetes mellitus. Am J Obstet Gynecol 1994; 171:685-691
13. Fern C, Bellini C, Desideri G, De Mattia G, et al: Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care 1996;19:504-506
14. Donatelli M, Hoffmann E, Colletti I, et al: Circulating endothelin-1 levels in type 2 diabetic patients with ischaemic heart disease. Acta Diabetol 1996;33:246-248
15. Saito M, Nishi K, Fukumoto Y, et al: Characterisation of endothelin receptors in streptozotocin-induced diabetic rat vas deferens. Biochem Pharmacol 1996;52:1593-1598
16. Saito M, Nishi K, Foster HE, et al: Effect of experimental diabetes on rat prostate endothelin receptors. Eur J Pharmacol 1996;310:197-200
17. Vesci L, Mattera GG, Tobia P, et al: Cardiac and renal endothelin-1 binding sites in streptozotocin-induced diabetic rats. Pharmacol Res 1995;32:363-367
18. Morabito E, Corsico N, Arrigoni Martelli E: Endothelins urinary excretion is increased in spontaneously diabetic rats: BB/BB. Life Sci 1995;6:13-18
19. Kamm KE, Stull JT: The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 1985;25:593-620
20. Huggins JP, Pelton JT, Miller RC: The structure and specificity of endothelin receptors: Their importance in physiology and medicine. Pharmacol Ther 1993;59:55-123
21. Murray C, Haverkamp AD, Orleans M, et al: Nifedipine for treatment of preterm labor: A historic prospective study. Am J Obstet Gynecol 1992;167:52-56
22. Bird LM, Anderson NC Jr, Chandler ML, Young RC: The effects of aminophylline and nifedipine on contractility of isolated pregnant human myometrium. Am J Obstet Gynecol 1987;157:171-177
23. Ferguson JE, Dyson DC, Schutz T, et al: A comparison of tocolysis with nifedipine and ritodrine for the treatment of preterm labor. Am J Obstet Gynecol 1990;163:105-111
24. van Zwieten PA, Pfaffendorf M: Similarities and differences between calcium antagonists: Pharmacological aspects. J Hypertens (suppl) 1993;11:S3-S11
25. van Zwieten PA, Pfaffendorf M, Mancia G: Attempts to improve the selectivity of calcium antagonistic drugs. Blood Press (suppl) 1996;5:7-9
26. Wide-Swensson D, Ingemarsson I, Arulkumaran S, et al: Effects of isradipine, a new calcium antagonist, on maternal cardiovascular system and uterine activity in labour. Br J Obstet Gynaecol 1990;97:945-949